Physician profile
Ethan Yoder
NPI 1942752944
$835.45
in general payments reported to CMS, 2019-2025
16 companies · $15.39 in 2025
The $15.39 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $350 · 2022: $372 · 2023: $65.21 · 2024: $33.55 · 2025: $15.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $364.33 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $99.60 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $66.71 | 2021-2024 | Spravato |
| Kestra Medical Technology Services, INC. | $45.25 | 2023 | Assure Wcd |
| Bausch Health US, LLC | $41.82 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $41.05 | 2022 | |
| Neuronetics, INC. | $22.39 | 2021 | |
| Avanir Pharmaceuticals, INC. | $19.91 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.33 | 2022 | |
| Alkermes, INC. | $18.84 | 2022 | |
| Lundbeck LLC | $17.72 | 2022 | |
| Eisai INC. | $17.30 | 2021 | |
| Neos Therapeutics, LP | $16.66 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.78 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.39 | 2025 | Cobenfy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.